Marsh & McLennan Companies, Inc. (MRSH)
Official siteFINANCIAL SERVICES • INSURANCE BROKERS • NYSE
Market Cap: $98.80B
Last updated: Nov 17, 2026 at 11:06 AM ET
Marsh & McLennan Companies, Inc. (MRSH) Stock Forecast
Analysts expect Marsh & McLennan Companies (MRSH) to earn $10.49 per share in the fiscal year ending Dec 31, 2026, on revenue of $28.74B. Of 23 analysts, 7 rate the stock Buy or Strong Buy, 15 Hold and 1 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 17 estimates for the fiscal year ending Dec 31, 2026 were revised up and 3 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 23 ratings average 2.70, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 30% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 2 | 8.7% |
| Buy | 5 | 21.7% |
| Hold | 15 | 65.2% |
| Sell | 0 | 0.0% |
| Strong Sell | 1 | 4.3% |
- Consensus
- Hold
- Total analysts
- 23
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 9.2% and revenue estimates rise 4.9%.
- Fiscal year ending Dec 31, 2026
- $10.49
- EPS consensus, revenue $28.74B
- Fiscal year ending Dec 31, 2027
- $11.46
- EPS consensus, revenue $30.15B
- Next report
- Jan 27, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $10.49 | $10.39 to $10.58 | 23 | $28.74B | $28.44B to $28.88B | 16 |
| Dec 31, 2027 | $11.46 | $10.96 to $11.76 | 23 | $30.15B | $29.49B to $30.79B | 16 |
Quarterly Estimates
The EPS consensus rises from $2.26 for the quarter ending Dec 31, 2026 to $3.58 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $2.26 | $2.08 to $2.39 | 26 | $7.03B | $6.64B to $7.37B | 19 |
| Mar 31, 2027 | $3.58 | $3.47 to $3.68 | 21 | $7.95B | $7.86B to $8.12B | 10 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 33 upward and 20 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 17 | 3 |
| Fiscal year ending Dec 31, 2027 | 12 | 6 |
| Quarter ending Mar 31, 2027 | 4 | 11 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 0.4% from $10.45.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $10.49 | $10.49 | $10.45 | $10.45 | $10.45 | +0.3% |
| Fiscal year ending Dec 31, 2027 | $11.46 | $11.46 | $11.42 | $11.41 | $11.41 | +0.5% |
| Quarter ending Mar 31, 2027 | $3.58 | $3.57 | $3.57 | $3.57 | $3.57 | +0.2% |
Frequently Asked Questions About MRSH
What is the MRSH stock forecast?
Consensus analyst estimates put Marsh & McLennan Companies's EPS at $10.49 for the fiscal year ending Dec 31, 2026, on revenue of $28.74B. The consensus rating from 23 analysts is Hold.
How do analysts rate MRSH stock?
Of 23 analysts covering Marsh & McLennan Companies, 2 rate it Strong Buy, 5 Buy, 15 Hold, 0 Sell and 1 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from MRSH next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $10.49, with estimates from $10.39 to $10.58 from 23 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $11.46, with estimates from $10.96 to $11.76 from 23 analysts.
What revenue do analysts expect from Marsh & McLennan Companies next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $28.74B, with estimates from $28.44B to $28.88B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $30.15B, with estimates from $29.49B to $30.79B.
How many analysts cover MRSH?
23 analysts rate Marsh & McLennan Companies stock, and 23 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
MRSH pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts